Alberti KG - Search Results

1

Features of syndrome X in first-degree relatives of NIDDM patients.

Stewart MW, Humphriss DB, Berrish TS, Barriocanal LA, Trajano LR, Alberti KG, Walker M. Stewart MW, et al. Among authors: alberti kg. Diabetes Care. 1995 Jul;18(7):1020-2. doi: 10.2337/diacare.18.7.1020. Diabetes Care. 1995. PMID: 7555535

2

Peripheral and hepatic insulin sensitivity in subjects with impaired glucose tolerance.

Berrish TS, Hetherington CS, Alberti KG, Walker M. Berrish TS, et al. Among authors: alberti kg. Diabetologia. 1995 Jun;38(6):699-704. doi: 10.1007/BF00401842. Diabetologia. 1995. PMID: 7672492

3

Cell membrane dynamics and insulin resistance in non-insulin-dependent diabetes mellitus.

Tong P, Thomas T, Berrish T, Humphriss D, Barriocanal L, Stewart M, Walker M, Wilkinson R, Alberti KG. Tong P, et al. Among authors: alberti kg. Lancet. 1995 Feb 11;345(8946):357-8. doi: 10.1016/s0140-6736(95)90343-7. Lancet. 1995. PMID: 7845118

4

Human insulin receptor substrate-1: variant sequences in familial non-insulin-dependent diabetes mellitus.

Armstrong M, Haldane F, Taylor RW, Humphriss D, Berrish T, Stewart MW, Turnbull DM, Alberti KG, Walker M. Armstrong M, et al. Among authors: alberti kg. Diabet Med. 1996 Feb;13(2):133-8. doi: 10.1002/(SICI)1096-9136(199602)13:2<133::AID-DIA7>3.0.CO;2-2. Diabet Med. 1996. PMID: 8641117

5

Metabolic heterogeneity in impaired glucose tolerance.

Walker M, Berrish TS, Stewart MW, Humphriss DB, Barriocanal L, Alberti KG. Walker M, et al. Among authors: alberti kg. Metabolism. 1997 Aug;46(8):914-7. doi: 10.1016/s0026-0495(97)90079-2. Metabolism. 1997. PMID: 9258274

6

Multiple metabolic abnormalities in normal glucose tolerant relatives of NIDDM families.

Humphriss DB, Stewart MW, Berrish TS, Barriocanal LA, Trajano LR, Ashworth LA, Brown MD, Miller M, Avery PJ, Alberti KG, Walker M. Humphriss DB, et al. Among authors: alberti kg. Diabetologia. 1997 Oct;40(10):1185-90. doi: 10.1007/s001250050805. Diabetologia. 1997. PMID: 9349600

7

Metabolic effects of suppression of nonesterified fatty acid levels with acipimox in obese NIDDM subjects.

Fulcher GR, Walker M, Catalano C, Agius L, Alberti KG. Fulcher GR, et al. Among authors: alberti kg. Diabetes. 1992 Nov;41(11):1400-8. doi: 10.2337/diab.41.11.1400. Diabetes. 1992. PMID: 1397716 Clinical Trial.

8

Clinical aspects of diabetic ketoacidosis.

Walker M, Marshall SM, Alberti KG. Walker M, et al. Among authors: alberti kg. Diabetes Metab Rev. 1989 Dec;5(8):651-63. doi: 10.1002/dmr.5610050803. Diabetes Metab Rev. 1989. PMID: 2515049 Review. No abstract available.

9

The effects of lipid lowering drugs on metabolic control and lipoprotein composition in type 2 diabetic patients with mild hyperlipidaemia.

Stewart MW, Dyer RG, Alberti KG, Laker MF. Stewart MW, et al. Among authors: alberti kg. Diabet Med. 1995 Mar;12(3):250-7. doi: 10.1111/j.1464-5491.1995.tb00467.x. Diabet Med. 1995. PMID: 7758262 Clinical Trial.

10

The contribution of lipids to coronary heart disease in diabetes mellitus.

Stewart MW, Laker MF, Alberti KG. Stewart MW, et al. Among authors: alberti kg. J Intern Med Suppl. 1994;736:41-6. J Intern Med Suppl. 1994. PMID: 7986307 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

839 results

Search Page

Filters